Table 1 Routine investigation of the patient

White blood cells (×10⁹/l)

7.1

4–10

Red blood cells (×10¹²/l)

4.56

3.5–5.5

Hemoglobin (g/dl)

12.5

12–16

Hematocrit (%)

37.3

35–47

Mean corpuscular volume (fl)

81.8

78–98

Mean corpuscular hemoglobin (pg)

27.4

26–35

Mean corpuscular hemoglobin concentration (%)

33.8

30–36

Red cell distribution width-CV (%)

11.7

11.5–14.5

Absolute lymphocyte count (×10⁹/l)

5.8

6–8.3

Absolute neutrophil count (×10⁹/l)

1.3

1.5–6.0

Platelet count (×10⁹/l)

345

150–400

Mean platelet volume (fl)

7.9

7.5–10.4

Platelet distribution width (fl)

9.3

9–17

Platelet-large cell ratio (%)

12.7

13–43

Reticulocyte count (%)

0.6

0.5–3%

Bilirubin total (mg/dl)

0.76

< 1.1

Bilirubin direct (mg/dl)

0.09

< 0.3

Total protein (g/dl)

7.4

6.6–8.3

Albumin (g/dl)

4.2

3.5–5.0

Alanine transaminase (ALT) (U/l)

22

Up to 41

Aspartate transaminase (AST) (U/l)

18

Up to 40

Alkaline phosphatase (ALP) (U/l)

120

< 300

Hepatitis C virus screening (HCV)

Negative

–

Hepatitis B virus screening (HBV)

Negative

–

Human immunodeficiency virus (HIV) screening

Negative

–